Expression of Long Non-Coding RNAs (UCA1 and CCAT2) in the Blood of Multiple Sclerosis Patients: A Case - Control Study

[1]  Ansar Karimian,et al.  Multiple Functions of Long Non‐Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer Progression , 2018, Journal of cellular biochemistry.

[2]  Y. Li,et al.  Knockdown of lncRNA CCAT2 inhibits endometrial cancer cells growth and metastasis via sponging miR-216b. , 2017, Cancer biomarkers : section A of Disease markers.

[3]  T. Tan,et al.  ‘Lnc’‐ing Wnt in female reproductive cancers: therapeutic potential of long non‐coding RNAs in Wnt signalling , 2017, British journal of pharmacology.

[4]  G. Liu,et al.  Pediatric protein metabolism techniques - a review. , 2017, European review for medical and pharmacological sciences.

[5]  Mohammad Taheri,et al.  Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis Patients , 2017, Journal of Molecular Neuroscience.

[6]  A. Sayad,et al.  Determination of cytokine levels in multiple sclerosis patients and their relevance with patients’ response to Cinnovex , 2017, Cytokine.

[7]  K. Wang,et al.  Dynamic regulation effect of long non-coding RNA-UCA1 on NF-kB in hippocampus of epilepsy rats. , 2017, European review for medical and pharmacological sciences.

[8]  A. Sayad,et al.  Myxovirus resistance protein A (MxA) polymorphism is associated with IFNβ response in Iranian multiple sclerosis patients , 2017, Neurological Sciences.

[9]  Tao Xi,et al.  Suppression of carboxylesterases by imatinib mediated by the down‐regulation of pregnane X receptor , 2017, British journal of pharmacology.

[10]  Yuanfang Zhu,et al.  The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis , 2016, Diagnostic Pathology.

[11]  Zhongqiang Zhang,et al.  Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis , 2016, Oncology letters.

[12]  Yuan Yin,et al.  LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p , 2016, Scientific Reports.

[13]  Massimo Santoro,et al.  Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis , 2016, Journal of Molecular Neuroscience.

[14]  H. Inoko,et al.  HLA genes as modifiers of response to IFN-β-1a therapy in relapsing-remitting multiple sclerosis. , 2016, Pharmacogenomics.

[15]  Ya Tuo,et al.  Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. , 2015, European review for medical and pharmacological sciences.

[16]  Jian Zhang,et al.  Elevated expression of CCAT2 is associated with poor prognosis in esophageal squamous cell carcinoma , 2015, Journal of surgical oncology.

[17]  K. Sigdel,et al.  The Emerging Functions of Long Noncoding RNA in Immune Cells: Autoimmune Diseases , 2015, Journal of immunology research.

[18]  Deidre J. Devier,et al.  Increase in NF-κB-sensitive miRNA-146a and miRNA-155 in multiple sclerosis (MS) and pro-inflammatory neurodegeneration , 2015, Front. Mol. Neurosci..

[19]  Yu-qin Pan,et al.  Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway , 2015, Oncotarget.

[20]  Xin Ma,et al.  Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma. , 2014, International journal of clinical and experimental pathology.

[21]  Peng Huang,et al.  UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution , 2014, Pathology.

[22]  Hongzhi Zheng,et al.  Iron deficiency without anemia causes maternal hypothyroxinemia in pregnant rats. , 2014, Nutrition research.

[23]  Rong Yin,et al.  CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer , 2014, Tumor Biology.

[24]  Y. Mo,et al.  Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1) , 2014, Cell Death and Disease.

[25]  J. Foekens,et al.  CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations , 2013, Oncotarget.

[26]  J. Foekens,et al.  CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer , 2013, Genome research.

[27]  Xiaobing Fu,et al.  Long Noncoding RNAs: Insights from Biological Features and Functions to Diseases , 2013, Medicinal research reviews.

[28]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[29]  Shao-Jun Tang,et al.  Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain , 2012, Journal of Neuroimmune Pharmacology.

[30]  Chen Yang,et al.  Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. , 2012, Gene.

[31]  M. Goldenberg.  Multiple sclerosis review. , 2012, P & T : a peer-reviewed journal for formulary management.

[32]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[33]  Xu Li,et al.  UCA1, a non‐protein‐coding RNA up‐regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion , 2008, FEBS letters.

[34]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[35]  J. Satoh,et al.  Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis , 2005, Neurobiology of Disease.

[36]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[37]  M. Pender.  Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis , 1998, The Lancet.

[38]  G. Lewis.  Continuum of self-destructiveness , 1998, The Lancet.

[39]  A. Federico,et al.  Advances in clinical neurology through the journal “Neurological Sciences” (2015–2016) , 2017, Neurological Sciences.

[40]  M. Hall,et al.  Understanding patient and provider perceptions and expectations of genomic medicine , 2015, Journal of surgical oncology.

[41]  S. Sawcer,et al.  The multiple sclerosis severity score , 2003 .